Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New VLA-4 inhibitors under development at Aventis

Aug. 23, 2000

Novel VLA-4 inhibitors reported by Elan and Wyeth-Ayerst

Aug. 23, 2000

Orally active dual NK1/NK2 antagonist synthesized by Schering-Plough

Aug. 22, 2000

Potent, selective human A2B adenosine receptor antagonists reported

Aug. 22, 2000

Suplatast tosilate improves asthma symptoms in a double-blind trial

Aug. 22, 2000

Novel PCP inhibitors under development at Roche

Aug. 16, 2000

Janssen receives patent for new antihistaminic series

Aug. 11, 2000

Pulmicort Respules approved in U.S. for children aged 1 to 8 years

Aug. 9, 2000

MSI-ipratropium trial reveals efficacy of new delivery system

Aug. 9, 2000

New alpha4-integrin antagonists useful for asthma, etc.

Aug. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...